By Reuters
NYT U.S.
The Trump administration has withdrawn a rule that it had said would lower drug prices by ending the system of prescription drug after-market discounts called rebates that drugmakers pay to pharmacy benefit managers.
Published date: July 11, 2019 at 03:15PM
Reuters
New York Times article
No comments:
Post a Comment